Ovulation Induction
2
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
M&
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Gedeon RichterMyo-inositol
Merck & Co.Recombinant FSH
Merck & Co.Recombinant FSH
Clinical Trials (3)
Total enrollment: 332 patients across 3 trials
Myo-inositol Versus Clomiphene Citrate in PCOS
Start: Jul 2020Est. completion: Jan 202212 patients
Phase 4Terminated
Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction
Start: Mar 2009Est. completion: Mar 2011310 patients
Phase 4Completed
Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?
Start: Jul 2025Est. completion: Jul 202710 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 332 patients
2 companies competing in this space